Blood dopamine beta-hydroxylase activity and noradrenaline levels in the developing white rat.
Dopamine beta-hydroxylase (DBH) (3,4-dihydroxyphenylethylamine, ascorbate:oxygen oxidoreductase (beta-hydroxylating) (EC 1.14.17.1) activity in serum of blood obtained by decapitation of white rats at 19, 20, and 21 days in utero, immediately after birth, and postnatally to 70 days, was measured. Noradrenaline (NA) and DBH in plasma from undisturbed, cannulated, postweaning rats were also assayed. During the last few days in utero and the first 2 postnatal days serum DBH activity tripled and then remained elevated during the suckling period. Upon weaning, serum DBH activity declined at first precipitously and then more slowly, until the adult level was reached around 70 days of age. This postweaning decrease in DBH activity was also observed with the cannulated animals. In contrast, plasma NA levels remained low and constant throughout the postweaning period. In suckling rats treated with 6-hydroxydopamine from 2 to 12 days of age, serum DBH activity decreased to less than half its initial value by day 8. It is suggested that the observed changes in serum DBH activity in fetal and postnatal rats reflect ontogenetic changes in sympathetic nerve terminals and that they are probably not correlated with release of NA.
D000375:Aging; D000818:Animals; D004299:Dopamine beta-Hydroxylase / Q000097:blood*; D005260:Female; D005333:Fetus / Q000378:metabolism; D006892:Hydroxydopamines / Q000494:pharmacology; D009638:Norepinephrine / Q000097:blood*; D011247:Pregnancy; D051381:Rats
D006892:Hydroxydopamines; D004299:Dopamine beta-Hydroxylase; D009638:Norepinephrine